{Etokimab: A Deep Analysis into the 2022981-44-6 Protein Etokimab, designated by the unique identifier 2022981-44-6, represents a novel protein currently undergoing therapeutic evaluation. This therapeutic agent, https://www.targetmol.com/compound/etokimab